Apolipoprotein E4 exaggerates diabetic dyslipidemia and atherosclerosis in mice lacking the LDL receptor.
about
Polymerase I and transcript release factor (PTRF) regulates adipocyte differentiation and determines adipose tissue expandability.CNF1 increases brain energy level, counteracts neuroinflammatory markers and rescues cognitive deficits in a murine model of Alzheimer's disease.Apolipoprotein E4 impairs macrophage efferocytosis and potentiates apoptosis by accelerating endoplasmic reticulum stressThermodynamic and structural destabilization of apoE3 by hereditary mutations associated with the development of lipoprotein glomerulopathyAmelioration of Metabolic Syndrome-Associated Cognitive Impairments in Mice via a Reduction in Dietary Fat Content or Infusion of Non-Diabetic Plasma.ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesisReduced phosphorylation of brain insulin receptor substrate and Akt proteins in apolipoprotein-E4 targeted replacement mice.Expression of human apolipoprotein E4 reduces insulin-receptor substrate 1 expression and Akt phosphorylation in the ageing liver.A possible structural basis behind the pathogenic role of apolipoprotein E hereditary mutations associated with lipoprotein glomerulopathy.The E. coli CNF1 as a pioneering therapy for the central nervous system diseases.Effects of adipocyte-secreted factors on decidualized endometrial cells: modulation of endometrial receptivity in vitro.Apolipoprotein E4 mediates insulin resistance-associated cerebrovascular dysfunction and the post-prandial response.γ-Secretase Inhibition Lowers Plasma Triglyceride-Rich Lipoproteins by Stabilizing the LDL Receptor.Hyperglycemia Aggravates Diet-Induced Coronary Artery Disease and Myocardial Infarction in SR-B1-Knockout/ApoE-Hypomorphic Mice
P2860
Q33913173-7A7DF0E4-852A-47D7-92A6-F72CA2A81020Q34759070-3B0DB3C8-9260-4724-B062-335EFAC7A611Q36201919-BC3FBE8D-B3A3-4556-96C6-65D57D28AE05Q36462050-F8449B8D-B47C-4F78-89E6-DEA03DF38C37Q36538782-168FD89C-3B44-4A25-B842-A793D9B82DB7Q36843340-E6578C1B-C14A-4FA0-BA3E-707D7DF66824Q37489258-378D1788-131A-4751-8541-053D88E85099Q37645475-A7E5F410-81DF-4D7A-B5ED-5BDC09C775B7Q38154771-7A7607BF-F880-4533-B554-108827CEB547Q38176761-EC3BD36D-6DF9-4316-8339-9B8BCAB5ED8FQ42830359-901F90DF-EB4F-4FCC-9FCD-E6B53C43DE0AQ50035045-903DE9DA-B6ED-4BB6-87BF-E5A856BA5A2EQ51735096-5E6F3190-95F8-4930-8256-139434D14CECQ57817035-3CBF5B46-9A08-446F-99F0-D7C02CC3A2C3
P2860
Apolipoprotein E4 exaggerates diabetic dyslipidemia and atherosclerosis in mice lacking the LDL receptor.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Apolipoprotein E4 exaggerates ...... mice lacking the LDL receptor.
@ast
Apolipoprotein E4 exaggerates ...... mice lacking the LDL receptor.
@en
type
label
Apolipoprotein E4 exaggerates ...... mice lacking the LDL receptor.
@ast
Apolipoprotein E4 exaggerates ...... mice lacking the LDL receptor.
@en
prefLabel
Apolipoprotein E4 exaggerates ...... mice lacking the LDL receptor.
@ast
Apolipoprotein E4 exaggerates ...... mice lacking the LDL receptor.
@en
P2093
P2860
P356
P1433
P1476
Apolipoprotein E4 exaggerates ...... mice lacking the LDL receptor
@en
P2093
Avani A Pendse
Hyung-Suk Kim
Michael K Altenburg
Nobuyo Maeda
Raymond G Fox
P2860
P304
P356
10.2337/DB11-0466
P407
P577
2011-08-01T00:00:00Z